EMN01

Title

A phase 3, intergroup multicentre, randomized, controlled 3 arm parallel group study to determine the efficacy and safety of lenalidomide in combination with dexamethasone (rd) versus melphalan, prednisone and lenalidomide (mpr) versus cyclophosphamide, prednisone and lenalidomide (cpr) in newly diagnosed multiple myeloma elderly subjects

Overview / Summary

Study details

Patient eligibility criteria

Newly diagnosed MM who are 65 years of age or older

Publications